Biden Team’s Misguided And Deadly COVID-19 Vaccine Strategy

The Washington Times Header

Vaccination ‘arms race’ could prove dangerous to the American public

The Biden administration’s strategy to universally vaccinate in the middle of the pandemic is bad science and badly needs a reboot.

This strategy will likely prolong the most dangerous phase of the worst pandemic since 1918 and almost assuredly cause more harm than good – even as it undermines faith in the entire public health system. Four flawed assumptions drive the Biden strategy. The first is that universal vaccination can eradicate the virus and secure economic recovery by achieving herd immunity throughout the country (and the world). However, the virus is now so deeply embedded in the world population that, unlike polio and smallpox, eradication is unachievable. SARS-CoV-2 and its myriad mutations will likely continually circulate, much like the common cold and influenza.

The second assumption is that the vaccines are (near) perfectly effective. However, our currently available vaccines are quite “leaky.” While good at preventing severe disease and death, they only reduce, not eliminate, the risk of infection, replication, and transmission. As a slide deck from the Centers for Disease Control has revealed, even 100% acceptance of the current leaky vaccines combined with strict mask compliance will not stop the highly contagious Delta variant from spreading.

The third assumption is that the vaccines are safe. Yet scientists, physicians, and public health officials now recognize risks that are rare but by no means trivial. Known side effects include serious cardiac and thrombotic conditions, menstrual cycle disruptions, Bell’s Palsy, Guillain Barre syndrome, and anaphylaxis.

Unknown side effects which virologists fear may emerge include existential reproductive risks, additional autoimmune conditions, and various forms of disease enhancement, i.e., the vaccines can make people more vulnerable to reinfection by SARS-CoV-2 or reactivation of latent viral infections and associated diseases such as shingles. With good reason, the FDA has yet to approve the vaccines now administered under Emergency Use Authorization.

The failure of the fourth “durability” assumption is the most alarming and perplexing. It now appears our current vaccines are likely to offer a mere 180-day window of protection – a decided lack of durability underscored by scientific evidence from Israel and confirmed by Pfizer, the Department of Health and Human Services, and other countries.

Here, we are already being warned of the need for universal “booster” shots at six-month intervals for the foreseeable future. The obvious broader point that militates for individual vaccine choice is that repeated vaccinations, each with a small risk, can add up to a big risk.

The collective risk is massive:

The most important reason why a universal vaccination strategy is imprudent tracks to the collective risk associated with how the virus responds when replicating in vaccinated individuals. …

The more people you vaccinate, the greater the number of vaccine-resistant mutations you are likely to get, the less durable the vaccines will become, ever more powerful vaccines will have to be developed, and individuals will be exposed to more and more risk.

What we should be doing:

A far more optimal strategy is to vaccinate only the most vulnerable. This will limit the amount of vaccine-resistant mutations and thereby slow, if not halt, the current vaccine arms race.

Fortunately, those most vulnerable represent a relatively small number; and these cohorts have already achieved high levels of vaccine acceptance. They include senior citizens, for whom the risk of serious disease or death increases exponentially with age, and those with significant comorbidities such as obesity, lung, and heart disease.

For much of the rest of the population, there’s nothing to fear but fear of the virus itself. This is particularly true if we have lawful outpatient access to a growing arsenal of scientifically proven prophylactics and therapeutics.

For example, there has been much controversy over ivermectin and hydroxychloroquine. Yet, with the emergence of a growing body of scientific evidence, we can be assured these two medicines are safe and effective in prophylaxis and early treatment when administered under a physician’s supervision. Numerous other useful treatments range from famotidine/celecoxib, fluvoxamine, and apixaban to various anti-inflammatory steroids, Vitamin D, and zinc.

The broader goal when administering these agents is to moderate symptoms and take death off the table, particularly for the unvaccinated. Unlike vaccines, these agents are generally not dependent on specific viral properties or mutations but instead mitigate or treat the inflammatory symptoms of the disease itself.

Using non-sterilizing “vaccines” in the face of an epidemic is madness, because it invites disaster. Mass vaccination with this first generation of so-called vaccines (real vaccines are sterilizing) achieves short term gain but likely long term pain.

By Dr. Robert Malone and Peter Navarro

Read Original Article on WashingtonTimes.com

The Washington Times
The Washington Timeshttps://www.washingtontimes.com/
The Washington Times is a trusted counterweight to mainstream media, delivering facts and commentary to inform and celebrate the American values of freedom, faith and family.

Columns

Was Pope Francis the Worst Pope Ever?

It has been said the recently passed 266th Pope...

LGBTQ™ Roundup: Groomers Gone Wild, Pt. II

Trans activist gets triggered by BBC reporter telling him he can't use women’s toilets, according to UK Supreme Court ruling on the legal definition of women.

In Trade War, China’s Chokehold on US Medicine Moves Into Spotlight

China’s iron grip on supply of critical drug ingredients has been years in the making, driven by Beijing’s strategic plan to dominate the pharma industry

College Football’s Spring rite

The Blue-White game, with the antiquated press box and a large section of the west stands now history and under renovation, marches on, but for how long?

Everything We Know About El Salvador Deportee Abrego Garcia

For more than five years, Kilmar Abrego Garcia was an adjudged illegal immigrant living on borrowed time in the United States.

News

Trump Admin Asks Supreme Court to Allow Prohibition on Troops With Gender Dysphoria

Trump admin is asking Supreme Court to halt federal judge’s order preventing it from implementing policy disqualifying individuals with gender dysphoria.

New Mexico Supreme Court Bans Former Judge From Exercising Judicial Authority

NM Supreme Court barred former judge from exercising judicial authority in future amid reports alleged TdA gang member was arrested living on his property.

DHS and Country Star John Rich Team Up for Urgent Livestream about Protecting Kids from Online Predators

Know2Protect hosted a livestream featuring DHS Special Agent Dennis Fetting and country music star John Rich on protecting children from online predators.

US Manufacturing Shows Signs of Improvement as Factory Output, Orders Tick Higher

U.S. manufacturing showed modest but meaningful improvement in April, according to data by S&P Global, which showed factory output and orders ticking higher.

Trump Admin Sued by a Dozen States in US Trade Court Over Tariffs

A dozen states on April 23 filed a lawsuit against the Trump administration in the U.S. Court of International Trade over its recently announced tariffs.

Supreme Court Seems Inclined to Let Energy Companies Sue California Over Emissions Rules

Supreme Court seemed inclined during oral argument to revive a lawsuit filed by energy companies over California’s tough vehicle emissions standards.

FBI: Losses From Internet Crime Surged 33 Percent in 2024, Topping $16 Billion

Internet-enabled crime cost victims in the U.S. more than $16.6 billion in 2024, a record-breaking 33% increase over previous year, according to FBI report.

Fed’s Kugler: No Rate Cuts in Sight as Inflation, Tariffs Fuel Uncertainty

Federal Reserve Gov. Adriana Kugler said she supports holding interest rates steady due to ongoing inflation risks and new tariffs
spot_img

Related Articles